President Trump just made an announcement that will shake up global manufacturing. Foreign companies, including Taiwan Semiconductor, are now under pressure. Build factories in the U.S. or face massive tariffs. October 1 is the deadline.
For pharmaceuticals, this is huge. A 100 percent tariff on any branded or patented drug entering the U.S. unless the company is building a plant here. Only projects already started or under construction are safe. On paper, it sounds like supply chain security. COVID showed how dependent America is on foreign factories for critical medicine. In reality, it is a giant shake-up. Multinationals now have to spend hundreds of millions building plants or risk losing access to the largest market in the world.
It does not stop at drugs. Upholstered furniture will face a 30 percent tariff. Kitchen cabinets and bathroom vanities will see 50 percent. Heavy trucks are at 30 percent. Companies that built decades of global supply chains have to rethink everything. Moving production is expensive and slow. Some things cannot be moved quickly.
Trump calls it a win for American jobs and security. That may be true. Factories, engineers, workers could come back. But it will be messy. Prices will rise. Inventory will shrink. Supply chains could break. Companies will have to make impossible decisions fast. Some will pay the tariffs. Some will pass costs to consumers. Everyone will feel it.